Espero Pharmaceuticals Announces Promotion of Nitrolingual® Pumpspray (nitroglycerin lingual spray)

JACKSONVILLE, Fla.–(BUSINESS WIRE)–Espero Pharmaceuticals, a specialty pharmaceutical company, assumed the U.S. promotional responsibility for Nitrolingual Pumpspray in an exclusive licensing agreement with G. Pohl-Boskamp GmbH&Co KG
Source: BusinessWire-Primary

Espero Pharmaceuticals Announces Promotion of Nitrolingual® Pumpspray (nitroglycerin lingual spray)